NCT01212432Unknown2 期
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
适应症
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Pharmacokinetics
研究概览
简要总结
Daptomycin kinetics in CRRT
- Trial with medicinal product
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Pharmacokinetics
时间窗: 2011
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)Critically IllHemodialysisNCT00663403University of Michigan8
Unknown
2 期
Daptomycin Pharmacokinetics in Continuous Veno-venous HemodiafiltrationBacteremiaNCT01171547University of Zurich15
已完成
1 期
Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)End-Stage Renal DiseaseNCT00490737Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)12
已完成
3 期
Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass SurgeryLate Effects of SurgeryStaphylococcus AureusSurgical Site InfectionNCT00701636Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center30
已完成
不适用
Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint InfectionsBone and Joint InfectionPatient Treated by DaptomycinNCT03209921Hospices Civils de Lyon23